SARS CoV 2 News and Research

RSS

Promising interim results for Sinopharm's inactivated whole-virion SARS-CoV-2 vaccine

The COVID-19 pandemic has led to intensive scientific efforts to bring about an effective vaccine for global distribution. Many different vaccine design approaches are underway. A recent study published in the journal The Lancet Infectious Diseases in October 2020 reports a potentially successful inactivated virus vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

19 Oct 2020

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Now, a new study presented on the preprint server bioRxiv in October 2020 describes the efficient design of an mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), based on the use of the viral receptor-binding domain (RBD) mRNA encapsulated in lipid nanoparticles (LNP).

19 Oct 2020

Scientists uncover important disease-fighting role for cells in the liver

Scientists at Scripps Research have uncovered an important disease-fighting role for cells called hepatocytes, which constitute most of the liver. The discovery could potentially be harnessed to develop new medicines for viral illnesses.

19 Oct 2020

Antigenic imprinting of sarbecovirus

A recent study published on the preprint server bioRxiv* in October 2020 shows that the design of a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) must consider the prior history of exposure to coronaviruses since these affect the antibody response to the virus.

19 Oct 2020

New lab test for detection of SARS-CoV-2 antibodies gives results more quickly than existing assays

Knowing you have developed antibodies against the SARS-CoV-2 virus after recovering from COVID-19 doesn't tell you everything about your immunity.

19 Oct 2020

Study tackles the role of the renin-angiotensin system on COVID-19 pathophysiology

Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.

19 Oct 2020

Student adherence to control measures could significantly reduce COVID-19 risk

Researchers at the University of Warwick in the UK have conducted a modeling study showing that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could readily spread among students in the university setting if non-pharmaceutical interventions (NPIs) are not properly adhered to.

19 Oct 2020

New project to use plasma jets to decontaminate vital medical equipment exposed to Covid-19 virus

A NEW project developed by Lancaster University's Health Innovation Campus and Material Science Institute will see pioneering technology used to decontaminate vital medical equipment exposed to the Covid-19 virus, via a partnership with University Hospitals of Morecambe Bay NHS Foundation Trust.

19 Oct 2020

Melatonin may increase survival chances among intubated COVID-19 patients

Researchers at Columbia University in New York have conducted a study showing that patients with coronavirus disease 2019 (COVID-19) who require intubation and mechanical ventilation due to respiratory distress may benefit from treatment with the hormone melatonin.

19 Oct 2020

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.

19 Oct 2020

Oral antiseptics and mouthwashes may have the ability to neutralize human coronavirus

Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.

19 Oct 2020

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

‘KNAUER Wissenschaftliche Geräte GmbH’ and its new subsidiary 'Das Labor. GmbH' produce reliable Corona antibody tests in Sub-Saharan Africa.

From KNAUER Wissenschaftliche Geräte GmbH 19 Oct 2020

CBD could reduce lung damage caused by COVID-19

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

19 Oct 2020

Microbiology expert examines antiviral activities of Respiratory Detox Shot

Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).

19 Oct 2020

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.

19 Oct 2020

Scientists lay out a novel rationale for COVID-19 drug design

American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design - blocking a molecular "scissor" that the virus uses for virus production and to disable human proteins crucial to the immune response.

19 Oct 2020

Engineers visualize how speaking spreads a virus

A team of researchers and engineers at Princeton University has provided a visualization of how speaking produces and expels saliva droplets into the air. The smallest droplets can be inhaled by people, which is the primary mode of transmission of infections such as COVID-19.

19 Oct 2020

Study of patterns of social contacts early on in COVID-19 pandemic

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compelled people worldwide to quarantine. To mitigate the transmission of SARS-CoV-2, countries and workplaces have been under varying stages of lockdown since the detection of the infection in December 2019 in Wuhan, China.

19 Oct 2020

Concerti algorithm identifies intra-patient heteroplasmies in SARS-CoV-2 patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in Wuhan, China, in late 2019 has caused the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has affected more than 39.8 million lives globally and claimed over 1.11 million deaths to date.

18 Oct 2020

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Researchers in China have conducted a phase 1/2 trial demonstrating the safety, tolerability, and immunogenicity of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

18 Oct 2020

SARS CoV 2 News and Research

Promising interim results for Sinopharm's inactivated whole-virion SARS-CoV-2 vaccine

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Scientists uncover important disease-fighting role for cells in the liver

Antigenic imprinting of sarbecovirus

New lab test for detection of SARS-CoV-2 antibodies gives results more quickly than existing assays

Study tackles the role of the renin-angiotensin system on COVID-19 pathophysiology

Student adherence to control measures could significantly reduce COVID-19 risk

New project to use plasma jets to decontaminate vital medical equipment exposed to Covid-19 virus

Melatonin may increase survival chances among intubated COVID-19 patients

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

Oral antiseptics and mouthwashes may have the ability to neutralize human coronavirus

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

CBD could reduce lung damage caused by COVID-19

Microbiology expert examines antiviral activities of Respiratory Detox Shot

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Scientists lay out a novel rationale for COVID-19 drug design

Engineers visualize how speaking spreads a virus

Study of patterns of social contacts early on in COVID-19 pandemic

Concerti algorithm identifies intra-patient heteroplasmies in SARS-CoV-2 patients

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News